Foster Jonathan P. 4
4 · Moleculin Biotech, Inc. · Filed Nov 6, 2025
Insider Transaction Report
Form 4
Foster Jonathan P.
EVP & CFO
Transactions
- Exercise/Conversion
Common Stock
2025-11-04+20,625→ 308,212 total - Exercise/Conversion
Common Stock
2025-11-04$0.50/sh−5,023$2,496→ 303,189 total - Exercise/Conversion
Restricted Stock Units
2025-11-04−20,625→ 1,017,695 total→ Common Stock (20,625 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Shares withheld for payment of taxes upon vesting of restricted stock unit awards.
- [F3]On November 4, 2024, the reporting person was granted 82,500 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.